Revium Recovery, Inc. (RVRC)
1.43
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Revium Recovery Shareholders Equity (Quarterly) : 18.10M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 18.10M |
| June 30, 2025 | 18.53M |
| March 31, 2025 | 18.60M |
| December 31, 2024 | 18.79M |
| September 30, 2024 | 19.29M |
| June 30, 2024 | 5.276M |
| March 31, 2024 | 5.454M |
| December 31, 2023 | 1.392M |
| September 30, 2023 | -0.15M |
| June 30, 2023 | 0.01M |
| March 31, 2023 | 0.187M |
| December 31, 2022 | 0.39M |
| September 30, 2022 | 0.586M |
| June 30, 2022 | 0.415M |
| March 31, 2022 | 0.617M |
| December 31, 2021 | 0.936M |
| September 30, 2021 | 1.187M |
| June 30, 2021 | 1.31M |
| March 31, 2021 | 1.492M |
| December 31, 2020 | 1.253M |
| September 30, 2020 | -0.1243M |
| June 30, 2020 | -0.074M |
| March 31, 2020 | -0.0672M |
| December 31, 2019 | -0.0091M |
| September 30, 2019 | -0.0074M |
| Date | Value |
|---|---|
| June 30, 2019 | -0.0074M |
| March 31, 2019 | -0.0074M |
| December 31, 2018 | -0.0049M |
| September 30, 2018 | -0.0049M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 16.67M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 269.56M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 13.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.79M |
| Total Liabilities (Quarterly) | 0.693M |